The FDA has approved Allergan’s Botox to treat lower-limb spasticity in children, further extending the use of the drug – widely used as a wrinkle treatment – in therapeutic indications.
But Botox remains a very important product for Allergan with therapeutic revenues of nearly $398 million in the first quarter alone, up 5.8% compared with last year’s Q1. Cosmetic revenues in Q1 ...
Mitchell Brin has a license plate that says "Botox." Brin's been researching Botox since 1984 and is currently the chief scientific officer of Botox at the drug company Allergan. It's one of many ...
Brent Saunders, the CEO of Allergan, the pharmaceutical company that makes Botox explains all of its current and projected uses. Follow TI: On Facebook More from Tech Botox is famous for treating ...
He allegedly reassured his patients that any side effects were temporary and that the Botox was from Allergan, the veritable maker, according to prosecutors. "Luther's disregard for the health of ...
Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, today announced Allergan Medical Institute (AMI) will open three new ...
dermatologists began to pick up on the off-label use of Botox. It was then that Actavis, a drug company that specializes in generic drugs and over-the-counter products, scooped up Allergan for a ...
Since its first aesthetic approval for BOTOX® Cosmetic (onabotulinumtoxinA), Allergan Aesthetics has led the industry, ensuring excellence in training to empower aesthetic providers to deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback